Two-Year Real-World Results for Aflibercept Using the Treat-and-Extend Regimen in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Huang, Chu-HsuanChu-HsuanHuangTSO-TING LAICHANG-HAO YANGYI-TING HSIEH2024-01-182024-01-182024-012193-8245https://scholars.lib.ntu.edu.tw/handle/123456789/638590To evaluate the real-world efficacy of aflibercept using the treat-and-extend (TnE) regimen in treating neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV), and to analyze biomarkers using optical coherence tomography (OCT) to predict treatment outcomes.enAflibercept; Age-related macular degeneration; Polypoidal choroidal vasculopathy; Treat-and-extend regimen; Vascular endothelial growth factorTwo-Year Real-World Results for Aflibercept Using the Treat-and-Extend Regimen in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathyjournal article10.1007/s40123-023-00850-6379950142-s2.0-85177636750https://api.elsevier.com/content/abstract/scopus_id/85177636750